Mupadolimab
Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73POS B cells[1].
Product Specifications
CAS Number
[2451856-97-4]
Product Name Alternative
CPI-006
UNSPSC
12352203
Target
CD73
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/mupadolimab.html
Purity
99.43
Solubility
10 mM in DMSO
Smiles
[Mupadolimab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Miller R A, et al. Clinical results with a B cell activating anti-CD73 antibody for the immunotherapy of Covid-19. medRxiv, 2021.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2063540-01 0.1 mL
HRP-Linked Polyclonal Antibody to Collagen Type IV Alpha 5 (COL4a5)
Ask
View Details MBS2063540-02 0.2 mL
HRP-Linked Polyclonal Antibody to Collagen Type IV Alpha 5 (COL4a5)
Ask
View Details